HIV Case Study Day - HIV and Aging

Tuesday, October 19, 2021, 9:30 AM - 1:00 PM

Older patients are more likely to be diagnosed with HIV late in the course of their disease. A person may receive a delayed diagnoses because health care providers may not always test older patients for HIV infection, and older patients may mistake HIV symptoms for signs of normal aging and don’t consider HIV as a possible cause they should discuss with their provider. Stigma is also a concern because it can have a negative impact on the quality of life and may prevent a patient from disclosing their HIV status or seeking the health care and social services needed. The efficacy of ARVs has decreased the probability of AIDS-defining illnesses, but many HIV-associated non-AIDS co-morbidities occur frequently in older people with HIV, such as cardiovascular disease, diabetes, renal disease, and cancer. HIV and ARVs can also have effects on the brain. People aging with HIV can suffer from a range of cognitive, motor, and/or mood disorders.

This conference will discuss the importance of testing and screening older patients, the complexities of care and treatment and recognizing conditions that necessitate referral. Participants will also review legal documents for patients to consider should they become incapacitated and unable to express their desire for their medical care.

1. Describe the clinical treatment and stigma challenges of persons aging with HIV and screen patients for age related co-morbidities.
2. Discuss conditions of the brain in older patients and determine when referral and further screening is warranted.
3. Explain legal documents that are necessary to assist in developing an estate plan.

Complimentary

Pre-Registration is required for all participants. ONLY pre-registrants will be allowed into the conference. Registration will close on Friday, October 14, 2021.

In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Method of Participation

In order to meet the learning objectives and receive continuing education credit, participants are required to attend for the duration of the program, and complete the online evaluation form at the conclusion of the activity. A letter certifying attendance and credit certification will be available via CloudCME upon completion of the online evaluation survey.

Planners and speakers have no conflicts of interest to disclose regarding this educational activity.

There is no commercial support or sponsorship for this activity.

Questions?

[email protected]

AMA PRA Category 1 Credits™ (3.00 hours), Non-Physician Attendance (3.00 hours), ANCC Contact Hours (3.00 hours)